Home
|
Inbox
|
Search
|
View Abstract
Cost Illness of RSV Infection in Colombia
Description
.abstract img { width:300px !important; height:auto; display:block; text-align:center; margin-top:10px } .abstract { overflow-x:scroll } .abstract table { width:100%; display:block; border:hidden; border-collapse: collapse; margin-top:10px } .abstract td, th { border-top: 1px solid #ddd; padding: 4px 8px; } .abstract tbody tr:nth-child(even) td { background-color: #efefef; } .abstract a { overflow-wrap: break-word; word-wrap: break-word; }
A3686 - Cost Illness of RSV Infection in Colombia
Author Block: J. A. Buendia, D. Sinisterra; Faculty of Medicine. Department of Pharmacology and Toxicology, University of Antioquia, Medellin, Colombia.
Introduction: Data economic burden of RSV infection is scarce. This study was conducted to assess health care resource utilization and associated costs , among Children Hospitalized with Respiratory syncytial virus infection in Rionegro, Antioquia, ColombiaMethods: Children with RSV infection admitted between January 2015 and December 2016 to Clinica Somer, Antioquia, Colombia, were included in this analysis. RSV-related health care resource utilization and direct cost was collected. We included only the direct medical costs (management cost, drug administration, supportive medications) . Neither indirect costs nor direct non-medical costs were considered.) Results: RSV was detected in 46.4% (CI 95% 41.9-50.8%), of hospitalized children with Bronchiolitis (94 in 2016 and 108 in 2015). Ages ranging between 2 months and 10 months (median: 5.41), and 57.92 % were males. The average length of hospital stay was 6.11 days (SD 0.51 days) and 13.7% were admitted to the ICU. 19.91%. The mean of oxygen saturation was 88, 71% (SD 0.4%) and complication rate associated with RSV was 12.87%. The average costs per patient were US$ 547 in 2015 and US$492 in 2016. Diagnostic tests and treatments with low level of evidence and weak recommendation (chest radiography, complete blood cell (CBC) counts, use of albuterol, epinephrine, antibiotics, systemic or inhaled corticosteroids and chest physiotherapy) accounted for 23% in 2015 and 25% in 2016 of the mean annual costs per patientConclusions: One in four dollars is spent on resources with a low level of evidence in children with RSV infection. Prevention of RSV infection can prevent not only the unsafe exposure of patients to unnecessary treatments, but also contribute significantly to the saving of economic resources in health
Author Block: J. A. Buendia, D. Sinisterra; Faculty of Medicine. Department of Pharmacology and Toxicology, University of Antioquia, Medellin, Colombia.
Introduction: Data economic burden of RSV infection is scarce. This study was conducted to assess health care resource utilization and associated costs , among Children Hospitalized with Respiratory syncytial virus infection in Rionegro, Antioquia, ColombiaMethods: Children with RSV infection admitted between January 2015 and December 2016 to Clinica Somer, Antioquia, Colombia, were included in this analysis. RSV-related health care resource utilization and direct cost was collected. We included only the direct medical costs (management cost, drug administration, supportive medications) . Neither indirect costs nor direct non-medical costs were considered.) Results: RSV was detected in 46.4% (CI 95% 41.9-50.8%), of hospitalized children with Bronchiolitis (94 in 2016 and 108 in 2015). Ages ranging between 2 months and 10 months (median: 5.41), and 57.92 % were males. The average length of hospital stay was 6.11 days (SD 0.51 days) and 13.7% were admitted to the ICU. 19.91%. The mean of oxygen saturation was 88, 71% (SD 0.4%) and complication rate associated with RSV was 12.87%. The average costs per patient were US$ 547 in 2015 and US$492 in 2016. Diagnostic tests and treatments with low level of evidence and weak recommendation (chest radiography, complete blood cell (CBC) counts, use of albuterol, epinephrine, antibiotics, systemic or inhaled corticosteroids and chest physiotherapy) accounted for 23% in 2015 and 25% in 2016 of the mean annual costs per patientConclusions: One in four dollars is spent on resources with a low level of evidence in children with RSV infection. Prevention of RSV infection can prevent not only the unsafe exposure of patients to unnecessary treatments, but also contribute significantly to the saving of economic resources in health
|
Home
|
Inbox
|
Search
|